shanghai medicilon inc. announced that the Board of Directors received proposals from the company's actual controllers, Chairman Chen Jinzhang, and actual controllers, directors, and general manager CHUN-LIN CHEN on October 30, 2024, proposing that the company repurchase some of the company's issued Renminbi common shares (A shares) through the Shanghai Stock Exchange trading system in a centralized bidding trading manner. The purpose of the share repurchase is for stock-based incentives for employees' share ownership plans or for cancellation and reduction of the company's registered capital, with a total repurchase amount not less than RMB 50 million (inclusive) and not exceeding RMB 0.1 billion (inclusive). The repurchase period is within 6 months from the date when the shareholders' meeting approves the share repurchase plan.